Patients who have a first episode of venous thromboembolism (VTE) have an elevated risk
of a recurrent episode, and this necessitates secondary prophylaxis. Anticoagulant therapy …

The annual incidence of diagnosed venous thromboembolism (VTE) is 1 to 2 events per
1000 of the general population. VTE is very uncommon before age 20 years and, after 40 …

ContextWidespread screening of patients with venous thromboembolism (VTE) for
thrombophilic risk factors has become common clinical practice. Because of the increasing …

Venous thromboembolism (VTE) is a common disorder that can affect apparently healthy as
well as hospitalized patients. The actual incidence and prevalence of this disease are …

Background: The evidence on the optimal duration of treatment in patients with an idiopathic
venous thromboembolic event (VTE) is inconclusive. d-dimer testing to predict recurrent VTE …

Essentials• Long‐term recurrence risk of venous thromboembolism (VTE) is uncertain.• We
performed a prospective cohort study of 839 patients with first unprovoked VTE.• VTE …

Recurrent venous thromboembolism (VTE) is associated with increased morbidity and
mortality. This risk is lowered by anticoagulation, with a large effect in the initial phase …

Introduction Venous thromboembolism (VTE) carries a considerable risk of recurrence and
anticoagulants should be administered for a minimum of three months. Since little is known …

Contemporary data from population studies on the incidence and complications of venous
thromboembolism (VTE) are limited. An observational cohort study was undertaken to …

Currently available anticoagulants are effective in reducing the recurrence rate of venous
thromboembolism (VTE). However, anticoagulant treatment is associated with an increased …